A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine

By Dahlöf Carl   Jones Martin   Davis Kim   Loftus Jane   Salonen Reijo  

The Journal of Headache and Pain, Vol. 5, Iss. 2, 2004-08 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg

By Mauri Massimo Carlo   Turner Martin   Volonteri Lucia   Medori Rossella   Maier Wolfgang  

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 1, 2009-03 ,pp. : 36-47

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Zolmitriptan Nasal Spray 5 mg Has a Very Fast Onset of Action and Provides Sustained Pain Relief in the Treatment of Migraine

By Dowson Andrew J.   Gawel Marek   Charlesworth Bruce R.   Syrett Nick   Wilson Graham   Hughes Janette  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 261-266

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness and Patient Satisfaction with Zolmitriptan Nasal Spray 5 mg in Clinical Practice: A Patient Survey

By Hansen Steen Boes  

Headache Care, Vol. 2, Iss. 2, 2005-06 ,pp. : 127-136

Informa Healthcare

Access to resources Recommend Favorite

Intranasal Zolmitriptan 5 mg is Well Tolerated and Effective During Long-term Use for the Acute Treatment of Multiple Migraine Attacks

By Dowson Andrew   Charlesworth Bruce   Diener Hans-Christoph   Boes Hansen Steen  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 315-318

Informa Healthcare

Access to resources Recommend Favorite